Literature DB >> 22367251

Uteroplacental insufficiency alters rat hippocampal cellular phenotype in conjunction with ErbB receptor expression.

Camille Fung1, Xingrao Ke, Ashley S Brown, Xing Yu, Robert A McKnight, Robert H Lane.   

Abstract

INTRODUCTION: Uteroplacental insufficiency (UPI) produces significant neurodevelopmental deficits affecting the hippocampus of intrauterine growth-restricted (IUGR) offspring. IUGR males have worse deficits as compared with IUGR females. The exact mechanisms underlying these deficits are unclear. Alterations in hippocampal cellular composition along with altered expression of neural stem cell (NSC) differentiation molecules may underlie these deficits. We hypothesized that IUGR hippocampi would be endowed with altered neuronal, astrocytic, and immature oligodendrocytic proportions at birth, with males showing greater cellular deficits. We further hypothesized that UPI would perturb rat hippocampal expression of ErbB receptors (ErbB-Rs) and neuregulin 1 (NRG1) at birth and at weaning to account for the short- and long-term IUGR neurological sequelae.
METHODS: A well-established rat model of bilateral uterine artery ligation at embryonic day 19.5 was used to induce IUGR.
RESULTS: As compared with gender-matched controls, IUGR offspring have altered hippocampal neuronal, astrocytic, and immature oligodendrocytic composition in a subregion- and gender-specific manner at birth. In addition, IUGR hippocampi have altered receptor type- and gender-specific ErbB-R expression at birth and at weaning. DISCUSSION: These cellular and molecular alterations may account for the neurodevelopmental complications of IUGR and for the male susceptibility to worse neurologic outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367251      PMCID: PMC3612538          DOI: 10.1038/pr.2012.32

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


Introduction

Uteroplacental insufficiency (UPI) is the most common cause of intrauterine growth restriction (IUGR) of a fetus in developed countries and leads to short- and long-term neurodevelopmental disabilities in the offspring. These disabilities include tonal abnormalities, difficulties in working memory, recognition memory, visual spatial tasks, behavior and concentration (1). Correlating with these functional deficits, neuroimaging has shown that hippocampal volume within the cortical gray matter is particularly reduced in human IUGR infants (2). In addition, IUGR male offspring demonstrate an increased severity of neurological impairment compared to IUGR female offspring (3, 4). The exact mechanisms underlying IUGR-associated neurodevelopmental disabilities are unclear. Furthermore, the male susceptibility to worse neurologic function is not completely understood. Using a bilateral uterine artery ligation model to induce UPI in the rat, our laboratory has previously shown that juvenile IUGR male offspring at postnatal day (P) 21 have decreased myelin basic protein-to-neuronal nuclei ratio in all subregions of the hippocampus (CA1, CA3, and dentate gyrus, DG) (5). In contrast, neurons and synaptic density were preserved at P21. The current study aims to determine the effects of UPI on hippocampal neuronal, astrocytic, and immature oligodendrocytic composition at birth (P0) to determine whether IUGR offspring are born with a different cellular composition which then changes as the offspring matures. A second aim of this study is to determine how UPI affects neural stem cells (NSCs), the progenitor cells that give rise to neurons and glia, when UPI is occurring. In particular, we will examine how UPI affects the molecules that govern NSC differentiation into neurons and glia. These molecules include the the ErbB receptors (ErbB-Rs) and their ligand, neuregulin 1 (NRG1). The ErbB receptor family includes ErbB2, ErbB3, and ErbB4. Once ErbB3 and ErbB4 bind to NRG1, they must heterodimerize with ErbB2 for cell fate regulation (6, 7). ErbB2 has no known endogenous ligand. We therefore hypothesized that IUGR rat hippocampi would have decreased number of neurons, astrocytes, and immature oligodendrocytes at P0, with males showing greater cellular deficits. We further hypothesized that UPI would perturb rat hippocampal expression of ErbB-Rs and NRG1 at P0 and P21 to account for the short-and long-term cellular changes of IUGR. To test these hypotheses, we employed our rat model of bilateral uterine artery ligation to induce UPI, producing asymmetrical IUGR pups born 20–25% lighter in weight but with demonstrable cerebral alterations (8–11). We focused on the hippocampus in this study because this structure is intimately involved in learning and memory, is particular susceptible to metabolic disturbances such as UPI (1, 12), and harbors a NSC niche within the DG (13).

Methods

University of Utah Animal Care Committee approved all procedures which were carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The rat model of UPI has been previously described (5, 14).

Animal perfusion for histology

P0 pups (n = 6/group from 3 separate control, CON, and 3 separate IUGR litters) were individually fixed via intracardiac perfusion with ice cold 0.9% normal saline (vWR, Radnor, PA), followed by ice cold 2% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA)/1.4% sodium cacodylate (Sigma-Aldrich, St. Louis, MO)/5% sucrose (vWR) for 10 min. Dissected whole brains were post-fixed at 4°C overnight, cryoprotected with 15% and 30% sucrose at 4°C overnight, and embedded in 2% gelatin, 0.9% NaCl, 0.05% NaN3 (Sigma-Aldrich) under freezing condition. They were sectioned coronally with a cryostat at 10 μm per section (Microm HM550, Microm International, Walldorf, Germany). Sections were collected sequentially on 10 consecutive Superfrost Plus slide (Fisher Scientific, Pittsburgh, PA) such that the 1st and every 10th section were on the same slide.

Nissl stain to quantify dorsal hippocampal subregional volumes at P0

Sections encompassing the dorsal hippocampal were soaked in decreasing ethanol (vWR) baths. After 2 brief deionized H2O (DH2O) washes, sections were incubated in cresyl violet stain (Sigma-Aldrich) (1.25 g cresyl violet acetate and 0.75 ml glacial acetic acid to 250 ml warm DH2O) for 2 min and washed in DH2O for 1 min. Sections were dehydrated by a series of increasing ethanol baths and finally cleared by Histoclear (AGTC Bioproducts, Wilmington, MA) for 5 min. Sections were covered with mounting medium, coverslipped, and examined under light microscopy at 15x and 30x magnifications.

Morphometric analyses of Nissl-stained dorsal hippocampi at P0

Hippocampal DG, CA3, and CA1 subregions of CON and IUGR groups at 30x magnification were outlined manually using NIH ImageJ software. Hippocampal subregional areas were calculated as a percentage of total hippocampal area. Since each section was 10 μm thick, we calculated each subregion’s volume according to the Cavaleri Principle where V=ΣA × P × t where V=total volume, ΣA=sum of measured areas, P=inverse of section sampling fraction, and t is section thickness (15). DG, CA3, and CA1 subregional volumes were generated for CON and IUGR groups.

Immunofluorescent labeling of neurons with neuronal nuclear antigen (NeuN), of astrocytes with glial fibrillary acidic protein (GFAP), and of immature oligodendrocytes with O1 at P0

Sections were blocked with 3% normal goat serum (NGS)/0.05% Triton X-100 (Sigma-Aldrich) for 1 h at RT, incubated with mouse IgG monoclonal anti-NeuN antibody (MAB377, Millipore, Billerica, MA) at 1:1000, rabbit polyclonal anti-GFAP antibody (ab7779, Abcam, Cambridge, MA) at 1:2000, or mouse IgM monoclonal anti-immature oligodendrocyte marker O1 antibody (MAB1327, R&D systems, Minneapolis, MN) at 1:2000 in 3% NGS/0.05% Triton X-100 overnight at 4°C. Sections were washed three times in phosphate-buffered saline (PBS, Sigma-Aldrich) for 10 min and exposed to either secondary fluorescence-labeled DyLightTM 488-conjugated affinipure goat anti-mouse IgG at 1:1000, Cy-3-conjugated goat anti-rabbit at 1:1000, or DyLightTM 549-conjugated affinipure goat anti-mouse IgM at 1:2000 (Jackson ImmunoResearch, West Grove, PA) in 3% NGS/0.05% Triton X-100 for 1h at RT. Cell nuclei were counterstained with 10ng/ml DAPI (Molecular Probes, Invitrogen, Eugene, OR). Sections were washed again three times in PBS, air-dried, and coverslipped using Fluoromount-G mounting medium (Southern Biotech, Birmingham, AL). Negative control sections underwent similar staining procedure except for primary antibodies. Sections were imaged with the Olympus Fluoview FV1000 multiphoton laser scanning confocal microscope (Olympus Imaging America Inc, Center Valley, PA) and taken at 10x and 20x magnification to encompass all subregions of the hippocampus (DG, CA3, and CA1).

Morphometric analyses of immunofluorescent staining at P0

Sections encompassing the dorsal hippocampi at Bregma level ~−3.0 according to (16) were used for quantification. The number of NeuN positive (NeuN+) neurons in DG, CA3, and CA1 was counted in the context of total DAPI+ cells using NIH ImageJ software. Due to subregional hippocampal volume differences, DAPI count was normalized to the subregion with the fewest cells. Since GFAP and O1 largely stain for cell processes, we quantified the relative amount of astrocytes or immature oligodendrocytes by GFAP+ or O1+ staining divided by normalized DAPI+ cell nuclei.

Western immunoblotting for ErbB-Rs and NRG1 at P0 and P21

Hippocampi were homogenized in ice cold RIPA buffer (n = 6/group with pups from 3 separate CON and 3 separate IUGR litters for each time point). Total protein concentration was determined by BCA Protein Assay (Pierce Biotechnology, Rockford, IL) using bovine serum albumin (Sigma-Aldrich) as standards. 100 μg of protein and molecular weight markers were separated by XT Criterion gel electrophoresis (Bio-Rad Laboratories, Hercules, CA) at 200 V for 1 h. After electrophoresis, proteins were transferred to polyvinylidene fluoride membranes (Millipore) overnight at 4°C. Post-transfer, membranes were blocked in 5% milk/Tris-buffered saline Tween (TBS-T) at RT for 1–1.5 h. Bound proteins were detected with antibodies against ErbB2 (ab2428, Abcam) 1:200 in 5% milk/TBS-T; ErbB3 (05–390, Millipore) 1:100 in 5% milk/TBS-T; ErbB4 (ab19391, Abcam) 1:100 in 5% milk/TBS-T; total NRG1 (ab2994, Abcam) 1:150 in 5% milk/TBS-T; GAPDH (2118, Cell Signaling Technology, Danvers, MA) 1:2000 in 5% milk/TBS-T at 4°C overnight. Membranes were probed with either horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibody at 1:2000–1:3000 in 5% milk (Cell Signaling) secondary antibody for 1 h at RT. Antibody signals were detected with Western Lighting enhanced chemiluminescence (PerkinElmer, Waltham, MA) and quantified with Kodak Image Station 2000R (Eastman Kodak/SIS, Rochester, NY). GAPDH served as loading control. Hippocampal GAPDH protein expression was determined to be unaltered in our IUGR model (data not shown).

Statistics

Immunofluorescent histochemical quantification of NeuN, GFAP, and O1, normalized to CON females to highlight gender differences, is expressed as absolute values in arbitrary units. Protein levels of ErbB receptors and NRG-1 are expressed as means ± SEMs which were also normalized to CON females. Data were analyzed with ANOVA using Tukey post hoc test for equal sample sizes. Statistical significance was declared at p<0.05.

Results

Dorsal hippocampal subregional volumes in CON and IUGR animals at P0

IUGR significantly decreased female DG volume at P0 compared to CON females (Fig. 1). IUGR, on the other hand, significantly decreased CA1 volume in males at P0 compared to CON males (Fig. 1). CON female and CON male hippocampal subregional volumes were similar (Fig 1).
Figure 1

Quantification of dorsal hippocampal DG, CA3, and CA1 subregional volumes at P0

Hippocampal subregional volumes are depicted as means ± SEMs in μm3. n = 6/group. *p<0.05 vs. Control Females DG, **p<0.05 vs. Control Males CA1.

Hippocampal neurons, astrocytes, and immature oligodendrocytes in control and IUGR animals at P0

In the DG, CON males had a baseline decrease in neuron number compared to CON females (Fig 3). IUGR decreased neuron number in the DG in females only (Figs. 2A, 3). In contrast, IUGR decreased the number of neurons in CA3 and CA1 regions in males only (Figs. 2B, 2C, 3).
Figure 3

Quantification of neuron number in CON and IUGR hippocampal subregions at P0

Quantification of neuron number in hippocampal DG (A), CA3 (B) and CA1 (C). Data are normalized to Control Females (CF) set at 100%. *p<0.05 vs. Control Females, **p<0.05 vs. Control Males.

Figure 2

NeuN, GFAP, and O1 immunofluorescent staining for neurons, astrocytes, and immature oligodendrocytes respectively in CON and IUGR hippocampal DG, CA3, and CA1 subregions at P0

Representative hippocampal NeuN and DAPI immunofluorescent microscopic images from DG (A) of Control Females (CF) and IUGR Females (IF), from CA3 (B) and CA1 (C) of Control Males (CM) and IUGR Males (IM). Representative hippocampal GFAP and DAPI immunofluorescent microscopic images from DG (D) and CA3 (E) of CM and IM. Representative hippocampal O1 and DAPI immunofluorescent microscopic images from CA1 (F) of CF and IF. n = 6/group. Scale bars represent 50μm.

Similar to DG neurons, CON males had a baseline decrease in the amount of astrocytes compared to CON females (Fig. 4). IUGR increased the amount of DG astrocytes in males only (Figs. 2D, 4). On the other hand, IUGR decreased the amount of CA3 astrocytes in males only (Figs. 2E, 4). IUGR did not significantly affect CA1 astrocytes in either gender (Fig. 4).
Figure 4

Quantification of relative amount of astrocytes in CON and IUGR hippocampal subregions at P0

Quantification of relative amount of astrocytes in hippocampal DG (A), CA3 (B), and CA1 (C). Data are normalized to Control Females (CF) set at 100%. *p<0.05 vs. Control Females, **p<0.05 vs. Control Males.

Lastly, IUGR did not significantly alter the amount of immature oligodendrocytes in DG or CA3 in either gender (Fig 5). IUGR significantly increased the amount of CA1 immature oligodendrocytes in females (Fig. 2F, 5) but decreased the amount of CA1 immature oligodendrocytes in males (Fig 5).
Figure 5

Quantification of relative amount of immature oligodendrocytes in CON and IUGR hippocampal subregions at P0

Quantification of relative amount of immature oligodendrocytes in hippocampal DG (A), CA3 (B), and CA1 (C). Data are normalized to Control Females (CF) set at 100%. *p<0.05 vs. Control Females, **p<0.05 vs. Control Males.

Hippocampal ErbB2 protein levels at P0 and P21

IUGR females at P0 increased hippocampal ErbB2 protein level compared to CON females (Fig. 6). On the other hand, IUGR males at P0 had similar ErbB2 protein levels as CON males. CON female and male had similar ErbB2 protein levels at baseline. At P21, CON males had an increased baseline ErbB2 protein level compared to CON females (Fig. 6). IUGR did not alter ErbB2 protein levels in either gender at this age (Fig. 6).
Figure 6

Quantification of hippocampal ErbB2 and ErbB3 protein levels at P0 and P21

Results are depicted as %means ± SEMs compared to Control Females set as 100% (n = 6/group/time point). Representative Western blots are depicted above the Western quantification. Control Females (CF); IUGR Females (IF); Control Males (CM); IUGR Males (IM). GAPDH acted as loading control. *p<0.05 vs. Control Females, **p<0.05 vs. Control Males.

Hippocampal ErbB3 protein levels at P0 and P21

IUGR males and females at P0 decreased ErbB3 protein levels compared to gender-matched CON (Fig. 6). CON female and male had similar ErbB3 protein levels at baseline. At P21, CON males had increased baseline ErbB3 protein level over CON females, similar to ErbB2 protein expression (Fig. 6). IUGR males showed a further increase in ErbB3 protein level over CON males.

Hippocampal ErbB4 protein levels at P0 and P21

At P0, CON males show an increased baseline ErbB4 protein level over CON females. IUGR did not alter ErbB4 protein levels in either gender at P0 (Fig. 7). IUGR also did not affect ErbB4 protein levels in either gender at P21 (Fig. 7).
Figure 7

Quantification of hippocampal ErbB4 and NRG1 protein levels at P0 and P21

Results are depicted as % means ± SEMs compared to Control Females set as 100% (n = 6/group/time point). Representative Western blots are depicted above the Western quantification. Control Females (CF); IUGR Females (IF); Control Males (CM); IUGR Males (IM). GAPDH acted as loading control. *p<0.05 vs. Control Females.

Hippocampal NRG1 protein levels at P0 and P21

At P0 and P21, IUGR females and males had similar hippocampal NRG1 protein levels as their age- and gender-matched CON (Fig. 7). Additionally, CON males at P21 had an increased NRG1 protein level compared to CON females (Fig. 7).

Discussion

The most important finding of this study is that an acute UPI insult alters hippocampal neuronal, astrocytic, and immature oligodendrocytic composition in the rat IUGR offspring at birth in a region- and gender-specific manner. Along with altered hippocampal cellular composition, ErbB receptor expression is also altered in a receptor- and gender-specific manner. Collectively, these data provide a link of how the altered IUGR hippocampal cellular phenotype may result from altered NSC differentiation molecules such as the ErbB-R. In our model, IUGR rat offspring showed a decrease in hippocampal neuron number at birth. This neuronal decrease is consistent with neuronal decreases observed in other animals of UPI (17, 18). However, important differences in our finding compared to these studies are in the region- and gender-specificity of these neuronal changes. While other models have shown decreased number of neurons within one brain region only, i.e. in the cerebral cortex or hippocampal CA1, our investigation separated the three main subregions of the hippocampus to highlight regional differences. Additionally, we separated our analyses based on gender in an attempt to understand whether being an IUGR male or female would portend different outcomes. What we found was that IUGR decreased hippocampal CA1 and CA3 neurons, while IUGR females decreased DG neurons. Possible explanations for such region- and gender-specific neuronal decreases are multiple. CA1 and CA3 neurons arise separately by location and timing from the DG neurons during embryonic life. CA1 and CA3 neurons which originate from the Ammonic neuroepithelium are produced mostly on E17 to E20 in the rat brain. DG neurons which originate from the dentate neuroepithelium are produced mostly on E18 to E22 (19, 20). The molecular control governing these morphogenetic events is also known to be region-specific (21). Additionally, neurons in hippocampal subregions possess different intrinsic vulnerability to injury. A recent study demonstrated that prenatal stress (PNS) in pregnant rats elicited increased spine density on CA1 pyramidal neurons in male pups only (22). Furthermore, PNS altered DG granular neuron spine-density, dendritic length and complexity in opposite directions in male and female offspring. Together, neurons from different brain regions and from different genders will behave differently in response to an insult because of their inherent region and sex-autonomous differences. Another explanation for our observed region- and gender-specificity may relate to the fact that neurons in IUGR male hippocampi are exposed to an environment of testosterone-estradiol imbalance. We have previously shown that our IUGR males at birth have increased serum testosterone level in association with decreased hippocampal aromatase expression while IUGR females do not (23). Aromatase is the enzyme responsible for the conversion of testosterone to its metabolite estradiol. The exposure of the developing brain to a balanced testosterone and estradiol ratio is critical for proper neuronal development (24). Therefore, over-exposure of the earlier formed CA1 and CA3 neurons to an excess of testosterone in our IUGR male rats may account for the selective regional neuronal loss. In addition to neuronal decreases, UPI elicited region- and gender-specific astrocytic and immature oligodendrocytic changes at birth. Important to highlight here is that unlike neurons, IUGR males possessed opposing amounts of astrocytes in CA1 and CA3 regions of the rat hippocampus compared to control males. Opposing astrocytic amount in other chronic insults of UPI have been demonstrated in the cortices of guinea pigs and rabbits (25, 26). But the opposing astrocytic amount within subregions of one brain structure has not been seen previously. The etiology of these astrocytic differences remains unclear. We speculate that some of our explanations pertaining to the subregional neuronal differences may account for the subregional differences observed in astrocytes as well. In terms of our findings with immature oligodendrocytes, UPI in this model produced a strong gender difference in the hippocampal CA1 region. Of importance to highlight is that IUGR males had decreased amount of immature oligodendrocytes at birth. From our previous work, IUGR males had decreased amount of myelin basic protein-to-neuronal nuclei ratio in the same region at P21 (5). The current finding adds to the previous result by suggesting that the reduction in CA1 oligodendrocytic precursors at birth reduced the capacity to generate mature myelin basic protein at P21. Such an overall reduction in CA1 myelin basic protein will negatively affect the hippocampal function of IUGR males in the long term as CA1 neurons are responsible for sending the main hippocampal output back to the cortex for information processing (27). The region- and gender-specific neuronal and glial changes observed in our model suggest that NSC differentiation is altered by UPI. ErbB receptors and their ligand, NRG1, are known to play critical roles in neuronal and glial development from NSCs (6, 28). Mice deficient in ErbB2, 3, or 4 receptor have all died at relatively early stages of development, making a complete analysis of the central nervous system phenotype difficult. ErbB2 null mice show marked abnormalities of their cranial ganglia (29), while ErbB4 null mice have abnormal innervation of the brainstem (30). Furthermore, ErbB receptors are known to be localized in NSCs of both rodents and humans (31–33). Within the germinal epithelia of the developing Sprague-Dawley rat brain, ErbB2 and ErbB4 mRNAs have been found to be widely distributed as early as E12 (31). As rat brain development progressed, ErbB2 mRNA was mainly confined to the cells of the ventricular zone, while ErbB4 mRNA was mainly localized to the cells of the subventricular zone. These zones represent NSC niches in the developing and adult brain. In our current study, IUGR females at birth decreased hippocampal ErbB3 receptor despite no change in NRG1 ligand expression. Hippocampal ErbB3 receptor decrease occurs in conjunction with ErbB2 receptor increase. Since ErbB3 receptor lacks intrinsic kinase activity and must heterodimerize with ErbB2 for downstream signaling (34), the increase in ErbB2 receptor may signify a compensatory response to the IUGR decrease in ErbB3 level. Interestingly, IUGR males also showed decreased hippocampal ErbB3 receptor at birth but they lacked the ErbB2 receptor upregulation. Such a lack of ErbB2 receptor compensation may suggest that IUGR males are more susceptible to aberrant hippocampal morphogenesis due to their inability to transmit extracellular NRG1 signal for proper hippocampal NSC differentiation. This speculation is in part supported by the ErbB3 mutant mice who have a misshapened cerebellar plate that is poorly differentiated and contains fewer Purkinje cells compared to the wild-type (35). We understand that limitations to our study exist. We have only examined total NRG1 expression. NRG1 has at least 15 known isoforms arising from alternative promoter usage and RNA splicing; therefore other NRG1 isoforms may be altered as a result of UPI. Another limitation is the mixed population of NSCs, neurons, and glia within the rat hippocampus. Ideally, isolating NSCs from the hippocampus would generate a more cell-type specific NRG1 and ErbB receptor expression profile. Future studies using the NSC-specific nestin-green fluorescent protein transgenic mice will help to isolate a pure population of NSCs to elucidate the NSC-specific changes in ErbB receptor and NRG1. In conclusion, our study has delineated for the first time the natal hippocampal neuronal and glial phenotype in a model of UPI that has been in use since the 1960s. Given the current recognition of how many adult-onset neurocognitive and neuropsychiatric disorders may have origins in fetal life (36, 37), understanding how UPI affects the cellular makeup at birth and over time will open up mechanistic questions to address aberrant neural function in these IUGR offspring.
  36 in total

1.  Mosaic organization of the hippocampal neuroepithelium and the multiple germinal sources of dentate granule cells.

Authors:  J Altman; S A Bayer
Journal:  J Comp Neurol       Date:  1990-11-15       Impact factor: 3.215

Review 2.  Injury-induced neurogenesis in the adult mammalian brain.

Authors:  Jack M Parent
Journal:  Neuroscientist       Date:  2003-08       Impact factor: 7.519

3.  Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods.

Authors:  J Altman; S A Bayer
Journal:  J Comp Neurol       Date:  1990-11-15       Impact factor: 3.215

4.  The efficiency of systematic sampling in stereology and its prediction.

Authors:  H J Gundersen; E B Jensen
Journal:  J Microsc       Date:  1987-09       Impact factor: 1.758

5.  Glial growth factor restricts mammalian neural crest stem cells to a glial fate.

Authors:  N M Shah; M A Marchionni; I Isaacs; P Stroobant; D J Anderson
Journal:  Cell       Date:  1994-05-06       Impact factor: 41.582

6.  The effects of intrauterine growth retardation on the development of neuroglia in fetal guinea pigs. An immunohistochemical and an ultrastructural study.

Authors:  I Nitsos; S Rees
Journal:  Int J Dev Neurosci       Date:  1990       Impact factor: 2.457

7.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor.

Authors:  M Gassmann; F Casagranda; D Orioli; H Simon; C Lai; R Klein; G Lemke
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

8.  Requirement for neuregulin receptor erbB2 in neural and cardiac development.

Authors:  K F Lee; H Simon; H Chen; B Bates; M C Hung; C Hauser
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

9.  Cerebral palsy and intrauterine growth in single births: European collaborative study.

Authors:  Stephen Jarvis; Svetlana V Glinianaia; Maria-Giulia Torrioli; Mary-Jane Platt; Maria Miceli; Pierre-Simon Jouk; Ann Johnson; Jane Hutton; Karla Hemming; Gudrun Hagberg; Helen Dolk; James Chalmers
Journal:  Lancet       Date:  2003-10-04       Impact factor: 79.321

10.  ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice.

Authors:  S L Erickson; K S O'Shea; N Ghaboosi; L Loverro; G Frantz; M Bauer; L H Lu; M W Moore
Journal:  Development       Date:  1997-12       Impact factor: 6.868

View more
  18 in total

Review 1.  Early-Life Nutritional Programming of Cognition-The Fundamental Role of Epigenetic Mechanisms in Mediating the Relation between Early-Life Environment and Learning and Memory Process.

Authors:  Laura Moody; Hong Chen; Yuan-Xiang Pan
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

Review 2.  Development of the cerebral cortex and the effect of the intrauterine environment.

Authors:  Sebastian Quezada; Margie Castillo-Melendez; David W Walker; Mary Tolcos
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

3.  Maternal Calorie Restriction Causing Uteroplacental Insufficiency Differentially Affects Mammalian Placental Glucose and Leucine Transport Molecular Mechanisms.

Authors:  Amit Ganguly; Marlin Touma; Shanthie Thamotharan; Darryl C De Vivo; Sherin U Devaskar
Journal:  Endocrinology       Date:  2016-08-05       Impact factor: 4.736

4.  Assessment of in vivo fetal growth and placental vascular function in a novel intrauterine growth restriction model of progressive uterine artery occlusion in guinea pigs.

Authors:  Emilio A Herrera; René Alegría; Marcelo Farias; Farah Díaz-López; Cherie Hernández; Ricardo Uauy; Timothy R H Regnault; Paola Casanello; Bernardo J Krause
Journal:  J Physiol       Date:  2016-02-02       Impact factor: 5.182

5.  IUGR disrupts the PPARγ-Setd8-H4K20me(1) and Wnt signaling pathways in the juvenile rat hippocampus.

Authors:  Xingrao Ke; Bohan Xing; Baifeng Yu; Xing Yu; Amber Majnik; Susan Cohen; Robert Lane; Lisa Joss-Moore
Journal:  Int J Dev Neurosci       Date:  2014-08-11       Impact factor: 2.457

Review 6.  The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome.

Authors:  Suzanne L Miller; Petra S Huppi; Carina Mallard
Journal:  J Physiol       Date:  2016-01-05       Impact factor: 5.182

7.  Taurine improves the differentiation of neural stem cells in fetal rats with intrauterine growth restriction via activation of the PKA-CREB-BDNF signaling pathway.

Authors:  Qiong Fang; Jing Liu; Lang Chen; Qiaobin Chen; Jun Ke; Jiuyun Zhang; Ying Liu; Wei Fu
Journal:  Metab Brain Dis       Date:  2021-02-20       Impact factor: 3.584

8.  Taurine supplementation improves hippocampal metabolism in immature rats with intrauterine growth restriction (IUGR) through protecting neurons and reducing gliosis.

Authors:  Qiong Fang; Jing Liu; Lang Chen; Qiaobin Chen; Yan Wang; Zuanfang Li; Wei Fu; Ying Liu
Journal:  Metab Brain Dis       Date:  2022-01-20       Impact factor: 3.655

Review 9.  Neurological outcomes of animal models of uterine artery ligation and relevance to human intrauterine growth restriction: a systematic review.

Authors:  Alfred Basilious; Jerome Yager; Michael G Fehlings
Journal:  Dev Med Child Neurol       Date:  2014-10-21       Impact factor: 5.449

10.  Intrauterine growth restriction followed by oxygen support uniquely interferes with genetic regulators of myelination.

Authors:  Jill Chang; Robert H Lurie; Abhineet Sharma; Mirrah Bashir; Camille M Fung; Robert W Dettman; Maria L V Dizon
Journal:  eNeuro       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.